Humalog Side Effects: FDA Label Numbers | Dose Track

Humalog side effects

insulin lispro injection · mealtime injection under the skin, insulin pump (U-100) or IV (U-100); vial, KwikPen, Junior KwikPen, Tempo Pen, cartridge · Label checked

Low blood sugar (hypoglycemia) is the most common Humalog side effect, as with all insulin.

In the label's type 1 trial, flu syndrome affected 34.6%, pharyngitis 33.3% and headache 29.6%, close to regular human insulin. In type 2, headache affected 11.6%. The Patient Information also lists injection site reactions, skin pits or thickening, weight gain, swelling, itching and rash. Humalog has no boxed warning.

At a glance

Boxed warning
None
Serious risk
Who should not use it (section 4)
First in the label table
Flu syndrome
Serious risks listed
9
Form
Mealtime injection under the skin, insulin pump (U-100) or IV (U-100); vial, KwikPen, Junior KwikPen, Tempo Pen, cartridge
Log Humalog side effects next to each dose in Dose Track →

When does the label say to call your doctor?

From the Patient Information that comes with Humalog:

  • Signs of a severe allergic reaction, such as a rash over your whole body, trouble breathing, a fast heartbeat or sweating: get medical help right away.
  • Trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue or throat, sweating, extreme drowsiness, dizziness or confusion: get emergency medical help.
  • New or worse symptoms of heart failure while taking a TZD with Humalog, such as shortness of breath, swelling of your ankles or feet, or sudden weight gain: tell your healthcare provider.

What are the most common Humalog side effects?

These are the label's own numbers from the Adverse Reactions section. Where the label compares with placebo (a dummy treatment), both columns are shown, so you can see how much more often a reaction happened on Humalog.

Show the label table (18 rows)Hide table
Table 1: Adverse Reactions That Occurred in ≥5% in Patients with Type 1 Diabetes Mellitus [Section 6.1]
Adverse reactionHUMALOG, % (n=81)Regular human insulin, % (n=86)
Flu syndrome34.632.6
Pharyngitis33.333.7
Rhinitis24.729.1
Headache29.622.1
Pain19.816.3
Cough increased17.317.4
Infection13.620.9
Nausea6.215.1
Accidental injury8.611.6
Surgical procedure6.214.0
Fever6.211.6
Abdominal pain7.48.1
Asthenia7.48.1
Bronchitis7.47.0
Diarrhea8.65.8
Dysmenorrhea6.27.0
Myalgia7.45.8
Urinary tract infection6.24.7

Common reactions excluding low blood sugar, at 5% or more on insulin lispro or regular human insulin. The comparison is regular human insulin, not placebo.

Table 2: Adverse Reactions That Occurred in ≥5% in Patients with Type 2 Diabetes Mellitus [Section 6.1]
Adverse reactionHUMALOG, % (n=714)Regular human insulin, % (n=709)
Headache11.69.3
Pain10.810.0
Infection10.17.6
Pharyngitis6.68.2
Rhinitis8.16.6
Flu syndrome6.28.2
Surgical procedure7.46.8
Table 3: Catheter Occlusions and Infusion Site Reactions [Section 6.1]
MeasureHUMALOG U-100 (n=38)Regular human insulin (n=39)
Catheter occlusions/month0.090.10
Infusion site reactions2.6% (1/38)2.6% (1/39)

A 12-week crossover study of adults with type 1 diabetes using an insulin pump (n=39).

Other numbers in the Adverse Reactions section

  • Section 6.1In a 16-week pump study of children with type 1 diabetes, infusion site reactions were similar for insulin lispro and insulin aspart: 21% of 100 patients versus 17% of 198. The most frequent were infusion site redness and infusion site reaction.
  • Section 6.1In controlled trials, itching (with or without rash) was seen in 30 of 2944 patients on Humalog and 17 of 2969 on regular human insulin. The label gives these as counts, not percentages.
Show 4 more findingsShow fewer
  • Section 6.1Redness, swelling or itching at the injection site usually clears in a few days to a few weeks, but sometimes means stopping Humalog. Metacresol, an inactive ingredient, has been linked to site reactions and general muscle aches.
  • Section 6.1Fast improvement in blood sugar control has been linked to a temporary change in eye focus, worsening diabetic eye disease and painful nerve symptoms. Weight gain, swelling from sodium retention and skin pits or thickening (lipodystrophy) can also occur.
  • Section 6.1Anti-insulin antibodies rose most in people new to insulin, peaked by 12 months and then declined. The label says they did not appear to worsen blood sugar control or require more insulin.
  • Section 6.2Reported after approval: other insulins given by mistake in place of Humalog, and localized cutaneous amyloidosis (lumps under the skin) at injection sites. Injecting into those lumps has raised blood sugar, and a sudden switch to normal skin has lowered it.

What serious risks does the Humalog label warn about?

The Warnings and Precautions part of the label lists these. Each line gives the label's heading and what it means in plain words.

  • Section 4Who should not use it. Humalog is not used during an episode of low blood sugar, or by people allergic to insulin lispro or any of its inactive ingredients.
  • Section 5.1Never share a pen, cartridge or syringe. Pens, cartridges and reusable pens are never shared, even if the needle is changed, and vial users never share needles or syringes, because of the risk of passing on blood-borne infections.
  • Section 5.2Changes in insulin regimen. Changing insulin strength, maker, type, injection site or method can cause high or low blood sugar, so changes are made under close medical supervision with more glucose checks. In type 2 diabetes, other diabetes medicines may need adjusting.
  • Section 5.3Low blood sugar. Hypoglycemia is the most common reaction to insulin. Severe episodes can cause seizures or death and can affect driving. Awareness of lows may be reduced with long diabetes, nerve damage, beta-blockers or repeated lows. Kidney or liver problems can raise the risk.
Show 5 more risksShow fewer
  • Section 5.4Medication mix-ups. Mix-ups between insulins have been reported, so the label is checked before each injection. Humalog U-200 is never drawn from the pen into a syringe: syringe markings will not measure it correctly, which can cause an overdose and severe low blood sugar.
  • Section 5.5Serious allergic reactions. Severe, life-threatening whole-body allergy, including anaphylaxis, can occur; Humalog is stopped if it does.
  • Section 5.6Low potassium. All insulins shift potassium into cells and can cause low potassium, which untreated can cause breathing paralysis, heart rhythm problems and death.
  • Section 5.7Heart failure with TZDs. Thiazolidinediones (such as pioglitazone) with insulin can cause fluid retention that may lead to or worsen heart failure.
  • Section 5.8Insulin pump failure. A pump or infusion set malfunction, or degraded insulin, can quickly lead to high blood sugar and ketoacidosis. Pump users are trained to give insulin by injection and keep backup insulin on hand.

Does Humalog have a boxed warning?

No. The current Humalog label has no boxed warning.

How do I keep track of side effects in Dose Track?

Dose Track has a side-effect log. Each entry records the symptom, a severity (none, mild, moderate, severe or life-threatening), the date and an optional note, and can be tied to a specific dose or logged on its own.

Read moreRead less

The history screen shows what you logged over time, which makes it easier to tell your prescriber when a reaction started and whether it is easing. The app records what you enter; it does not judge whether a symptom is serious. For anything on the label's call-your-doctor list, call your doctor.

Frequently asked questions

What is the most common side effect of Humalog?

Low blood sugar (hypoglycemia), the most common reaction to all insulins (sections 5.3 and 6.1). In the type 1 trial, flu syndrome (34.6%), pharyngitis (33.3%) and headache (29.6%) were the most common other reactions, at rates close to regular human insulin (section 6.1, Table 1).

Does Humalog cause headaches?

Headache was reported in 29.6% on Humalog versus 22.1% on regular human insulin in type 1 diabetes, and 11.6% versus 9.3% in type 2 diabetes (section 6.1, Tables 1 and 2).

Does Humalog have a boxed warning?

No. The Humalog label has no boxed warning. Its warnings cover sharing pens, regimen changes, low blood sugar, mix-ups, allergic reactions, low potassium, heart failure with TZDs and pump failure (section 5).

Does Humalog cause weight gain?

It can. The label says weight gain has occurred with insulins including Humalog, attributed to insulin's anabolic effects and less sugar lost in the urine (section 6.1).

Does Humalog cause injection site reactions?

It can. Redness, swelling or itching at the site usually clears in days to weeks (section 6.1). In a pump study, infusion site reactions affected 2.6% on Humalog U-100 (section 6.1, Table 3).

Show similar medicinesShow fewer

Sources

  1. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use, prescribing information and Patient Information. Eli Lilly and Company. DailyMed, version published August 10, 2026. DailyMed setid c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f
What Humalog is approved forHide

Humalog is a rapid-acting mealtime insulin approved to improve blood sugar control in adults and children with diabetes (section 1).

This page is what the FDA label says, in plain words. It is not medical advice. Follow your prescriber, and ask them or your pharmacist about anything here.

All side-effect pages · Dosing schedules · Missed dose guides · Compound guides